JENNIFER CARTER: Open Payments
NPI 1902246150 · TAHLEQUAH, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$203 in 11 payments from 9 companies in 2025. Trend: 2023 $253 · 2024 $0 · 2025 $203
Food & beverage: $203
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Lilly USA, LLC | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Intercept Pharmaceuticals, Inc. | 1 | $20 |
| Celltrion USA Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| ABBVIE INC. | 1 | $15 |
| Janssen Biotech, Inc. | 1 | $14 |
Products named: VOQUEZNA, IQIRVO, OCALIVA, VEGZELMA, XIFAXAN, RINVOQ, TREMFYA.
Industry payments across OK — which companies pay providers there.
